These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8675617)

  • 1. Why there is an IRS.
    O'Brien RM; Granner DK
    J Clin Invest; 1995 Dec; 96(6):2546. PubMed ID: 8675617
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between primary gout and hypertriglyceridaemia may be due to genetic linkage.
    Ferns GA; Lanham J; Galton DJ
    Monogr Atheroscler; 1985; 13():121-3. PubMed ID: 3937047
    [No Abstract]   [Full Text] [Related]  

  • 3. [Familial hypertriglyceridemia].
    Kuwasako T; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():74-8. PubMed ID: 11347165
    [No Abstract]   [Full Text] [Related]  

  • 4. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
    Li WW; Dammerman MM; Smith JD; Metzger S; Breslow JL; Leff T
    J Clin Invest; 1995 Dec; 96(6):2601-5. PubMed ID: 8675624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haplotypes identified by DNA restriction-fragment-length polymorphisms in the A-1 C-III A-IV gene region and hypertriglyceridemia.
    Stocks J; Paul H; Galton D
    Am J Hum Genet; 1987 Aug; 41(2):106-18. PubMed ID: 2887109
    [No Abstract]   [Full Text] [Related]  

  • 6. The molecular genetics of hyperlipidemia.
    Shoulders CC; Baralle FE
    Horiz Biochem Biophys; 1986; 8():299-340. PubMed ID: 2875933
    [No Abstract]   [Full Text] [Related]  

  • 7. The SstI polymorphism of the apo C-III gene is associated with insulin sensitivity in young men.
    Pérez-Jiménez F; López-Miranda J; Gómez P; Velasco MJ; Marín C; Pérez-Martínez P; Moreno JA; Paniagua JA
    Diabetologia; 2002 Aug; 45(8):1196-200. PubMed ID: 12189450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum apolipoprotein C III levels and apolipoprotein C III gene Sst I polymorphism with carotid intima-media thickness in Chinese type 2 diabetic patients.
    Chen X; Tian H; Liu R
    Diabetes Res Clin Pract; 2004 Oct; 66(1):41-7. PubMed ID: 15364160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From clinical tests to etiology: analysis of clinical features. Deficiency of apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1987 Dec; Spec No 75():93-108. PubMed ID: 3448286
    [No Abstract]   [Full Text] [Related]  

  • 10. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia.
    Rees A; Stocks J; Sharpe CR; Vella MA; Shoulders CC; Katz J; Jowett NI; Baralle FE; Galton DJ
    J Clin Invest; 1985 Sep; 76(3):1090-5. PubMed ID: 2995445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
    Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
    Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart disease.
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1987; 117():167-73. PubMed ID: 2977686
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure of the human apolipoprotein C-II gene promoter.
    Streicher R; Avci H; Munck M; Siemeister G; Geisel J; Weisshaar C; Müller-Wieland D; Krone W
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():49-50. PubMed ID: 8767460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics and molecular biology of apolipoprotein CII.
    Hayden MR; Vergani C; Humphries SE; Kirby L; Shukin R; McLeod R
    Adv Exp Med Biol; 1986; 201():241-51. PubMed ID: 3541518
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler A; Page G; Brown WV; Lyons TJ; Garvey WT;
    J Diabetes Complications; 2005; 19(1):18-25. PubMed ID: 15642486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA polymorphism of the apoprotein AII gene in hypertriglyceridaemia.
    Ferns GA; Shelley CS; Stocks J; Rees A; Paul H; Baralle F; Galton DJ
    Hum Genet; 1986 Nov; 74(3):302-6. PubMed ID: 2877939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in coronary artery disease].
    Dan Q; Huang Y; Peng Z
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):584-7, 637. PubMed ID: 8697070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs.
    Taş S
    Clin Chem; 1989 Feb; 35(2):256-9. PubMed ID: 2914370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo C-III levels in type IV hyperlipoproteinemia associated with non-insulin dependent diabetes.
    Shoukry MI
    Indian J Med Res; 1986 Sep; 84():297-300. PubMed ID: 3817933
    [No Abstract]   [Full Text] [Related]  

  • 20. SstI RFLP and hypertension as risk factors for extracoronary atherosclerosis in a male population of southern Italy.
    Pujia A; Gnasso A; Siclari D; Dominijanni A; Zingone A; Marasco O; Mele E; Cortese C; Colonna A; Mattioli PL
    Artery; 1994; 21(4):208-21. PubMed ID: 8830647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.